Blanket Purchase Agreement HHSN263201500072B

Award Date 3/31/15
Last Date to Order 1/31/24
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Health and Human Services' National Institutes of Health (NIH) awarded a single-award Blanket Purchase Agreement (BPA) to American Radiolabeled Chemicals, Inc., a minority-owned, small disadvantaged business. The $100 million BPA, with a period of performance through January 31, 2026, enables the flexible delivery of radioactive materials, radioisotopes, radionuclides, and non-radioactive chemicals to support biomedical research at NIH laboratories. American Radiolabeled...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Advanced Accelerator Applications USA Inc., a large, foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $23.4 million single-award BPA is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of February 3, 2025. The BPA is for the procurement of LOCAMETZ and NETSPOT, two...
This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Quality Biological Inc. (QBI), a minority-owned, self-certified small disadvantaged business, has a ceiling value of $100 million and a period of performance through November 30, 2025. The BPA covers the supply of a wide range of laboratory products and services, including reagents, media, laboratory plastics...
This Blanket Purchase Agreement (BPA) contract was awarded by the Department of Health and Human Services, National Institutes of Health to prime contractor Lonza LLC, a global partner to the pharmaceutical and specialty chemicals markets. The BPA is for the procurement of laboratory supplies and chemicals, with no set-aside designations. The contract has a total ceiling value of $0, as it represents an open-ended ordering mechanism rather than a fixed-value award. Task orders under the BPA...
This Blanket Purchase Agreement was awarded by the Department of Health and Human Services to VWR International LLC as a single-award IDV to provide laboratory supplies, glassware, chemicals, media, radionuclides/radioisotopes, biological materials, miscellaneous services, and medical/scientific equipment/maintenance/repair to various NIH institutes and centers. Task orders were placed against this BPA from 2015 to the present without any set-aside designations. Places of performance for task...
This Blanket Purchase Agreement (BPA) contract, awarded by the U.S. Department of Health and Human Services (HHS) to Research And Diagnostic Systems, Inc. (R&D Systems), provides a wide range of research materials and supplies to support various biomedical research projects across multiple HHS agencies, particularly the National Institutes of Health (NIH). The contract, which has a ceiling value of $0 and a period of performance ending October 31, 2024, allows for the procurement of growth...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Alkali Scientific, LLC as the prime contractor. The BPA is for the provision of various laboratory supplies and consumables, including blood/blood products, glassware, and other lab supplies, to support research efforts within the agency. The contract has a potential value of $0 and a period of performance...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency Contracting Activity (DHACA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to procure various radiopharmaceuticals for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The single-award, firm-fixed-price BPA is valued at $1,900,000.00 and has a performance period from October 1, 2024 to September 30, 2029. The BPA covers the acquisition of 31 different...
This Blanket Purchase Agreement (BPA) was awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the Department of Health and Human Services, to Alkali Scientific, LLC, a small disadvantaged business. The BPA has a ceiling value of $10,000,000 and a period of performance from April 23, 2024 to April 30, 2026. The BPA is intended to procure operation and maintenance items including blood/blood products, glassware, lab supplies, and biological materials to...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), to MBL International Corporation, a for-profit manufacturer of goods. The BPA covers the procurement of blood/blood products, biological materials, and chemicals. The BPA has no set-aside and was originally awarded on July 11, 2002, with an open-ended potential value. Under this BPA, three task orders have been issued to date. The first, awarded on December...
  • HHSN263201500072B
    Blanket Purchase Agreement
  • 4
    Federal Contract Awards

This Blanket Purchase Agreement was awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to American Radiolabeled Chemicals, Inc., a minority-owned, self-certified small disadvantaged business located in Bethesda, Maryland. The BPA establishes terms and conditions for the procurement of radionuclides, radioisotopes, chemicals, and biological materials to support research conducted by the National Institutes of Health.

Four task orders have been awarded against this BPA to date. The task orders provide a variety of radioactive and chemical materials for research at the National Institute of Mental Health in Bethesda, Maryland and the National Institute on Drug Abuse in Baltimore, Maryland. The total value of the four task orders is $32,666.10. Materials have included tritium, chemical assays, and other radioactive items. Prices are firm fixed. The base period of performance for the BPA is through January 2024, while task order periods vary and the longest extends into January 2023.

The BPA and associated task orders aim to efficiently procure specialized materials needed to support biomedical research at the National Institutes of Health. American Radiolabeled Chemicals, Inc. will provide a range of radionuclides and chemicals to further the agencies' efforts in areas such as mental health and substance abuse.

Generated 1/25/24, 9:06 AM